Autologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy(Beijing 302 Hospital)

N/A

Report date: 2023/06/19 20:00:35

Base Information

Drug NameAutologous T-cells Transfected With mRNA Encoding HBV-TCR T Cell Therapy(Beijing 302 Hospital)
Drug Alias NameAutologous T-cells Transfected With mRNA Encoding Hepatitis-B Virus (HBV)-Antigen-specific T Cell Receptor(Beijing 302 Hospital)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, HepatocellularHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesNo 302 Hospital Of The People Liberation Army Of China
China Registration ClassN/A

Develop Information

Active CompaniesNo 302 Hospital Of The People Liberation Army Of China
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A